These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21946722)

  • 21. Conclusions of the meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, November 2007.
    Wkly Epidemiol Rec; 2008 Sep; 83(37):341-7. PubMed ID: 18788147
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medical treatment of lymphatic filariasis].
    Hovette P; Laroche R; Verrot D; Molinier S; Touze JE
    Med Trop (Mars); 1991; 51(1):87-90. PubMed ID: 2072855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The end of lymphatic filariasis?
    Bockarie MJ; Molyneux DH
    BMJ; 2009 May; 338():b1686. PubMed ID: 19439451
    [No Abstract]   [Full Text] [Related]  

  • 25. Elimination of lymphatic filariasis in South East Asia.
    Specht S; Suma TK; Pedrique B; Hoerauf A
    BMJ; 2019 Jan; 364():k5198. PubMed ID: 30670373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current practices in the management of lymphatic filariasis.
    Bockarie MJ; Taylor MJ; Gyapong JO
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):595-605. PubMed ID: 19485799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.
    Showkath AM; Regu K; Rajendran R; Mohanan MK; Ganesh B
    J Commun Dis; 2008 Mar; 40(1):37-40. PubMed ID: 19127667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA.
    Kisoka WJ; Tersbøl BP; Meyrowitsch DW; Simonsen PE; Mushi DL
    J Biosoc Sci; 2016 Jan; 48(1):94-112. PubMed ID: 25790081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of albendazole for lymphatic filariasis.
    Horton J
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
    Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
    Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major progress toward eliminating lymphatic filariasis.
    Ottesen EA
    N Engl J Med; 2002 Dec; 347(23):1885-6. PubMed ID: 12466515
    [No Abstract]   [Full Text] [Related]  

  • 32. Eliminating Lymphatic Filariasis: Is it Worth it?
    Niessen LW; Taylor ML
    Clin Infect Dis; 2020 Jun; 70(12):2568-2569. PubMed ID: 31343066
    [No Abstract]   [Full Text] [Related]  

  • 33. Flubendazole in-feed preparation for prophylaxis of experimental lymphatic filariasis.
    Kumar V; Ghenim H; Brandt J; Vanparijs O
    Ann Soc Belg Med Trop; 1987 Mar; 67(1):75-7. PubMed ID: 3632079
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.
    El-Setouhy M; Abd Elaziz KM; Helmy H; Farid HA; Kamal HA; Ramzy RM; Shannon WD; Weil GJ
    Am J Trop Med Hyg; 2007 Dec; 77(6):1069-73. PubMed ID: 18165524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
    Ramaiah KD; Ravi R; Das PK
    Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lymphatic filariasis].
    Sante; 2000; 10(5):360-1. PubMed ID: 11221698
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.
    Cantey PT; Rao G; Rout J; Fox LM
    Trop Med Int Health; 2010 Feb; 15(2):224-31. PubMed ID: 20002615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 489 Global programme to eliminate lymphatic filariasis: progress report, 2014.
    Wkly Epidemiol Rec; 2015 Sep; 90(38):489-504. PubMed ID: 26387149
    [No Abstract]   [Full Text] [Related]  

  • 39. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2007 Oct; 82(42):361-80. PubMed ID: 17948605
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.